azd4635
Showing 1 - 4 of 4
Prostate Cancer, Metastatic Castration-Resistant Prostate Cancer (mCRPC) Trial in United States (AZD4635, Oleclumab, Durvalumab)
Active, not recruiting
- Prostate Cancer
- Metastatic Castration-Resistant Prostate Cancer (mCRPC)
- AZD4635
- +2 more
-
Denver, Colorado
- +8 more
Jan 12, 2023
Progressive Metastatic Castrate-Resistant Prostate Cancer Trial in Worldwide (AZD4635, Durvalumab, Cabazitaxel)
Active, not recruiting
- Progressive Metastatic Castrate-Resistant Prostate Cancer
- AZD4635
- +2 more
-
Sacramento, California
- +15 more
Mar 22, 2022
Advanced Solid Malignancies Trial in Chuo-ku, Kashiwa (AZD4635)
Completed
- Advanced Solid Malignancies
- AZD4635
-
Chuo-ku, Japan
- +1 more
Dec 7, 2020
Healthy Volunteer/DDI Study Trial in Harrow (AZD4635, Fluvoxamine)
Completed
- Healthy Volunteer/DDI Study
- AZD4635
- Fluvoxamine
-
Harrow, United KingdomResearch Site
Jan 5, 2021